You have 9 free searches left this month | for more free features.

[11C]EMO

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

Recruiting
  • Schizophrenia
  • +2 more
  • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
  • New Haven, Connecticut
    Connecticut Mental Health Center
Sep 16, 2022

Parkinson's Disease, Multiple System Atrophy, Dementia With Lewy Bodies Trial (C11-SY08)

Not yet recruiting
  • Parkinson's Disease
  • +3 more
  • (no location specified)
Oct 24, 2023

Inflammation in Alzheimer's Disease and Related Dementias Using

Recruiting
  • Alzheimer Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 9, 2023

Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)

Completed
  • Ketoses, Metabolic
  • Observational heart and kidney on siemens TEP scan
  • Sherbrooke, Quebec, Canada
    Research Center on Aging
Jan 16, 2023

ALS Trial ([11C]CPPC PET ligand)

Not yet recruiting
  • ALS
  • [11C]CPPC PET ligand
  • (no location specified)
Jan 9, 2023

Healthy Volunteers Trial in Solna ([11C]AZ14132516)

Not yet recruiting
  • Healthy Volunteers
  • Solna, Sweden
    Research Site
Apr 17, 2023

Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

Active, not recruiting
  • Tauopathies
  • 11C-HY-2-15 PET
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2023

11C-para-aminobenzoic Acid

Recruiting
  • Renal Excretion
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins Medical Institutions
Jan 30, 2023

Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)

Not yet recruiting
  • Crohn's Disease
  • Stockholm, Sweden
    Research Site
Sep 22, 2023

Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.

Not yet recruiting
  • Huntington Disease
  • [11C]UCB-J
  • [18F]SynVest-1
  • Leuven, Belgium
    UZ Leuven
Nov 2, 2022

Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism, Adrenal Tumors Trial in Singapore

Recruiting
  • Primary Aldosteronism Due to Aldosterone Producing Adenoma
  • +2 more
  • 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
  • Singapore, Singapore
  • +6 more
Oct 26, 2023

Diabetes, Type 2, Heart Failure, Healthy Trial in Aarhus N (3-[11C]-OHB)

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • 3-[11C]-OHB
  • Aarhus N, Jutland, Denmark
    Aarhus University Hospital
Nov 1, 2022

Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)

Recruiting
  • Cocaine Use Disorder
  • Baseline [C-11]NPA PET Scan
  • +2 more
  • Pittsburgh, Pennsylvania
    University of PIttsburgh
Jun 27, 2022

Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • FDG PET/CT scan
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Jan 10, 2023

MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)

Not yet recruiting
  • Major Depressive Disorder
  • Toludesvenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 7, 2023

CNS Tumor, Head and Neck Tumors Trial in Memphis (L-(11C) methionine)

Available
  • Central Nervous System Tumor
  • Head and Neck Neoplasms
  • L-(11C) methionine
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 19, 2022

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

Completed
  • Huntington Disease
  • [11C]CHDI-00485180-R
  • [11C]CHDI-00485626
  • Leuven, Belgium
    UZ Leuven
May 18, 2022

MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)

Recruiting
  • Major Depressive Disorder
  • Toludivenlafaxine hydrochloride sustained-release tablets
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Jun 14, 2023

Mild Cognitive Impairment Trial in Winston-Salem ([11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan)

Enrolling by invitation
  • Mild Cognitive Impairment
  • [11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
  • Winston-Salem, North Carolina
    Wake Forest School of Medicine
Dec 22, 2022

Amyotrophic Lateral Sclerosis Trial in Baltimore ([11C]CPPC Injection)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • [11C]CPPC Injection
  • Baltimore, Maryland
    Johns Hopkins Outpatient Center
Jul 11, 2022

Brain Cancer Trial in New York (PET scan, C-Choline)

Completed
  • Brain Cancer
  • PET scan
  • C-Choline
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 9, 2022

Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

Recruiting
  • Lymphangioleiomyomatosis
  • Tuberous Sclerosis Complex
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 20, 2022

Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)

Recruiting
  • Glioblastoma Multiforme
  • 11C-Methionine PET/CT
  • Brno, Czech Republic, Czechia
    Masaryk Memorial Cancer Institute
Nov 3, 2022

Lung in Pulmonary Artery Hypertension (PAH)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Healthy
  • TSPO PET scan (11C-PBR28)
  • (no location specified)
Feb 16, 2023